Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results

Go back to Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results
Biodrain Medical, Inc. (NASDAQ: BIOR) Delayed: 0.56 --0 (-0%)
Previous Close $0.56    52 Week High $0.30 
Open $0.56    52 Week Low $0.05 
Day High $0.56    P/E N/A 
Day Low $0.56    EPS $-0.19 
Volume 169,170